Publication date: Available online 16 November 2026 Source: Clinical Breast Cancer Author(s): Angela Theresa Zuffo Yabrude, Leila Caroline Souza Reis, Ana Elisa Saragossa Zafalon, Lorrany Larisse Costa Rodrigues, Clara Fish Araujo de Albuquerque, Eliza Del Fiol Manna
Public-Health Impact of Delayed Access to Neoadjuvant-Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in Brazil. // Clinical Breast Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1526820926001989?dgcid=rss_sd_all
Public-Health Impact of Delayed Access to Neoadjuvant-Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in Brazil. Clinical Breast Cancer. https://www.sciencedirect.com/science/article/pii/S1526820926001989?dgcid=rss_sd_all
“Public-Health Impact of Delayed Access to Neoadjuvant-Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in Brazil.” Clinical Breast Cancer.
@article{article40635,
title = {Public-Health Impact of Delayed Access to Neoadjuvant-Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in Brazil},
journal = {Clinical Breast Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1526820926001989?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment